Silvaco Group, Inc.
SVCO Nasdaq Services-Prepackaged Software Financials FY2023βFY2025
What Silvaco Group, Inc. does
No business description yet.
- Legal name
- Silvaco Group, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 12, 2026
- Accession Β· CIK
- 0001628280-26-017378
0001943289
Revenue and margins
Silvaco Group, Inc. had $63.1M of revenue in fiscal 2025, up 5.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$34.5M in fiscal 2025, β54.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Silvaco Group, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 15.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Silvaco Group, Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $4.4M | $82.7M | $10.0M |
| Debt incl. finance leases | $0.0M | β | β |
| Net debt / EBITDA | β2.5x | β | β |
| Debt / equity | 0.0x | β | β |
| Interest coverage | 1.8x | β44.8x | β |
| Current ratio | 0.8x | 3.1x | 1.2x |
| Quick ratio | 0.8x | 3.1x | 1.2x |
| Total assets | $40.9M | $142M | $123M |
| Total liabilities | $31.5M | $42.3M | $47.7M |
| Shareholders' equity | $9.4M | $100M | $75.0M |
| Net debt (β = net cash) | β$4.4M | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | 2 / 8 | 2 / 8 |
| Accruals ratio | β3.7% | β21.4% | β5.5% |
| Altman Z'' | 0.75 | 3.30 | β2.29 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $54.2M | $59.7M | $63.1M |
| Gross profit | $44.9M | $47.6M | $49.4M |
| Research and development | $13.2M | $20.7M | $29.9M |
| Operating income | $1.1M | β$40.3M | β$45.9M |
| Interest expense | $0.6M | $0.9M | β |
| Pretax income | $0.5M | β$38.9M | β$44.6M |
| Income tax | $0.8M | $0.5M | β$3.4M |
| Net income | β$0.3M | β$39.4M | β$41.2M |
| Diluted EPS | β$0.02 | β$1.53 | β$1.39 |
| Diluted shares | 0.02B | 0.03B | 0.03B |
| Cash flow | |||
| Cash from operations | $1.2M | β$19.8M | β$33.9M |
| Capital expenditure | $0.3M | $0.5M | $0.6M |
| Free cash flow | $0.8M | β$20.3M | β$34.5M |
| Depreciation and amortization | $0.6M | $1.3M | $3.5M |
| Stock-based compensation | $0.0M | $26.9M | $10.8M |
| Balance sheet | |||
| Cash and short-term investments | $4.4M | $82.7M | $10.0M |
| Total debt | $0.0M | β | β |
| Current assets | $20.9M | $107M | $46.1M |
| Current liabilities | $25.0M | $34.5M | $38.4M |
| Property and equipment, net | $0.6M | $0.9M | $1.5M |
| Goodwill | $9.0M | $9.0M | $30.1M |
| Intangible assets | $0.3M | $4.4M | $26.0M |
| Total assets | $40.9M | $142M | $123M |
| Total liabilities | $31.5M | $42.3M | $47.7M |
| Preferred stock | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $9.4M | $100M | $75.0M |
| Margins | |||
| Gross margin | 82.8% | 79.8% | 78.3% |
| Operating margin | 2.1% | β67.5% | β72.8% |
| EBITDA margin | 3.2% | β65.3% | β67.3% |
| Net margin | β0.6% | β66.0% | β65.3% |
| FCF margin | 1.6% | β34.0% | β54.7% |
| Returns | |||
| Return on capital | 14.8% | β | β |
| Return on capital employed | 7.1% | β37.3% | β54.5% |
| Return on equity | β3.4% | β72.0% | β47.1% |
| Return on assets | β0.8% | β43.0% | β31.1% |
| Return on tangible equity | β929.4% | β45.5% | β218.1% |
| Growth | |||
| Revenue growth | β | 10.0% | 5.7% |
| FCF growth | β | β2,511.3% | β |
| Share count change | β | 28.4% | 15.8% |
| Financial health | |||
| Net debt / EBITDA | β2.5x | β | β |
| Debt / equity | 0.0x | β | β |
| Interest coverage | 1.8x | β44.8x | β |
| Current ratio | 0.8x | 3.1x | 1.2x |
| Quick ratio | 0.8x | 3.1x | 1.2x |
| Capital allocation | |||
| Capex / revenue | 0.6% | 0.8% | 1.0% |
| Stock comp / revenue | 0.0% | 45.1% | 17.1% |
| Quality scores | |||
| Piotroski F-score | β | 2.0 | 2.0 |
| Altman Z'' | 0.7 | 3.3 | β2.3 |
| Accruals ratio | β3.7% | β21.4% | β5.5% |
Source: SEC EDGAR XBRL filings (CIK 0001943289). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.